Author:
Zhou Zhengyuan,Vaidyanathan Ganesan,McDougald Darryl,Kang Choong Mo,Balyasnikova Irina,Devoogdt Nick,Ta Angeline N.,McNaughton Brian R.,Zalutsky Michael R.
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference48 articles.
1. Schettini F, Buono G, Cardalesi C et al (2016) Hormone receptor/human epidermal growth factor receptor 2-positive breast cancer: where we are now and where we are going. Cancer Treat Rev 46:20–26
2. Santa-Maria CA, Nye L, Mutonga MB et al (2016) Management of metastatic HER2-positive breast cancer: where are we and where do we go from here? Oncology (Williston Park) 30:148–155
3. Recondo G Jr, de la Vega M, Galanternik F et al (2016) Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine. Cancer Manag Res 8:57–65
4. Maximiano S, Magalhaes P, Guerreiro MP, Morgado M (2016) Trastuzumab in the treatment of breast cancer. BioDrugs 30:75–86
5. Gebhart G, Flamen P, De Vries EG et al (2016) Imaging diagnostic and therapeutic targets: human epidermal growth factor receptor 2. J Nucl Med 57(Suppl 1):81S–88S
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献